News

Harbour BioMed Advances COPD Treatment with New Drug Submission

Harbour BioMed Advances COPD Treatment with New Drug Submission

Harbour BioMed Submits IND Application for Chronic Obstructive Pulmonary Disease

Harbour BioMed, a global player in biopharmaceutical innovation, has taken a significant step in the fight against chronic obstructive pulmonary disease (COPD) by submitting an Investigational New Drug (IND) application. This application was directed to the appropriate regulatory body for their novel therapy, HBM9378/SKB378. This fully human antibody is designed to target thymic stromal lymphopoietin (TSLP), an important factor in the progression of COPD.

The Burden of COPD and Need for Solutions

COPD is a progressive respiratory illness affecting millions globally. It not only leads to severe health complications but also places a heavy strain on healthcare systems worldwide. The disease is associated with increased risks of cardiovascular issues, respiratory failure, and even lung cancer. As the prevalence of COPD continues to rise, there is a pressing demand for innovative therapeutic options that can enhance the quality of life for those affected.

Innovative Approach of HBM9378/SKB378

HBM9378/SKB378 sets itself apart with its fully human sequences, significantly reducing the risk of immunogenicity seen in other TSLP-targeting therapies. This enhancement contributes to better bioavailability and dosing flexibility. According to Dr. Jingsong Wang, the company’s founder and CEO, the unique properties of HBM9378/SKB378 position it as a promising solution for COPD patients, aligning with their diverse needs.

Collaboration in Development

This innovative therapy arises from a co-development strategy between Harbour BioMed and Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Together, they hold global rights to this exciting project. The therapy is built on a sophisticated H2L2 platform, meaning it is generated from two heavy chains and two light chains, which enables it to effectively inhibit the crucial TSLP signaling pathway.

Clinical Trials and Future Prospects

While Harbour BioMed has already completed Phase I trials in China for HBM9378/SKB378 to address moderate-to-severe asthma, the current focus on COPD underlines the commitment to tackling complex respiratory issues. The results from these trials will be pivotal in assessing how effectively this monoclonal antibody can combat COPD.

About Harbour BioMed

Harbour BioMed specializes in the development of novel antibody therapeutics, with a strong spotlight on immunology and oncology. With a robust pipeline fueled by both in-house research and strategic partnerships, the company is dedicated to advancing medical science through innovative therapies. Their proprietary Harbour Mice® technology facilitates the creation of fully human monoclonal antibodies in various formats, ensuring they stay at the forefront of biopharmaceutical advancements.

Frequently Asked Questions

What is HBM9378/SKB378?

HBM9378/SKB378 is a fully human monoclonal antibody targeting TSLP, developed for the treatment of chronic obstructive pulmonary disease (COPD).

Why is COPD a significant health concern?

COPD results in major health complications and increasing healthcare costs. Its progressive nature necessitates effective treatment options to improve patient lives.

What makes HBM9378/SKB378 different from other therapies?

This therapy has a reduced immunogenicity risk and better bioavailability compared to competing treatments, enhancing its therapeutic effectiveness.

How is Harbour BioMed addressing COPD?

By submitting an IND application for HBM9378/SKB378, the company aims to bring a novel therapeutic option to patients suffering from COPD.

What are the future plans for this drug?

The outcomes from ongoing clinical trials will determine the next steps in development and potential approval for HBM9378/SKB378 as a COPD treatment.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

GARDANT Expands Reach with International Partnership

Updated Category News Views 33

GARDANT Global's Strategic Expansion Well, today we saw GARDANT Global make a move that screams ambition. They’re hooking up with International Offset Corporation (IOC) to muscle up their game in the murky waters of government procurement. Why does this matter? Because it's all about who gets the contracts, and with GARDANT’s newfound reach, they’re not just...

Continue Reading
Lifeway Foods Set to Announce Q3 2026 Financial Results

Updated Category News Views 8

Anticipating Lifeway Foods’ Q3 Results Dust off your calendars and mark November 12, 2026—because that's when Lifeway Foods is putting its cards on the table for the third quarter. Nothing like a results call to see if your investments are eating right. NASDAQ:LWAY is no stranger to making some noise in the dairy aisle, thanks to their kefir—that fermented probiotic...

Continue Reading
Anguilla: Paradise for Safe, Solo Beach Escapes

Updated Category News Views 0

A Safe Haven for Solo Adventurers You ever dream of escaping to a place where the world slows down and serenity reigns supreme? Somewhere you can kick back, soak up the sun, listen to the waves, and leave your worries behind? Well, folks, Tranquility Beach Anguilla fits that bill and then some. Why Anguilla Tops the List Let's talk about the accolades Anguilla has raked...

Continue Reading
From Missouri to Market: A New Spin on Turkey Calls

Updated Category News Views 29

Innovating the Turkey Call Game You want innovation? Well, wrap your head around this: a Missouri inventor is flipping the script on turkey mouth calls. The goal? To ditch the wrinkles and make turkey hunting that much smoother. It might seem a bit niche, but when you've been around long enough, you know these 'niche' ideas can sometimes hatch golden eggs for investors....

Continue Reading
Xyte's Record Quarter: Surging Demand & New CEO

Updated Category News Views 62

Setting New Records in the AV Industry There's buzz in the air over in Hoboken, New Jersey. Xyte, the AI cloud maestro you're starting to hear about more and more, has just smashed its own records this past September. It's not just a flash in the pan, either—this isn't the first time they've knocked it out of the park. Thanks to burgeoning enterprise demand and a...

Continue Reading
Vicuna Air Unveils Pet-Friendly European Routes

Updated Category News Views 72

Paws in the Sky: Vicuna Air's New Venture Look, when you hear about airlines, you're usually thinking delays, cramped seats, and overpriced peanuts—not four-legged companions jet-setting across the Atlantic. Yet, here comes Vicuna Air, flipping the script with their first continental European flights this October. They've got an ace up their sleeve: Brussels, now a...

Continue Reading
McKay Brothers Enhances Fastest Routes for Market Data

Updated Category News Views 0

Breaking Down McKay Brothers' Latest Maneuver Yeah, the financial market isn't just numbers and screens—it's about moving those numbers faster than a cheetah chasing prey. McKay Brothers knows this game inside and out, and they're laying down new wires, or rather, wireless, to make sure they've got the quickest routes in the room. Let me tell you, they're throwing money...

Continue Reading
LifeStance Expands Access to Esketamine, TMS

Updated Category News Views 0

LifeStance Health's Treatment Innovations Today, the spotlight is on LifeStance Health, as they're making waves with their treatment approaches for those battling stubborn, treatment-resistant depression. This isn't your run-of-the-mill attempt at tackling the beast—that familiar indifference masked as hope. No, this time around, they’re swinging with Esketamine and...

Continue Reading
Bravo Loans Bridge Gaps in Healthcare Real Estate

Updated Category News Views 0

Mezzanine Financing: A Vital Tool for Healthcare Owners Bravo Property Trust is throwing a lifeline to operators in the healthcare sector and beyond with their mezzanine loans aiming right between the eyes of the financing gap. This isn't just some loan for fun. It's a full-on financial tool designed to give some breathing room to folks owning or operating skilled nursing...

Continue Reading
ESENTIA Lifts EBITDA, Reduces Debt, Eyes Expansion

Updated Category News Views 109

ESENTIA Flexes Financial Muscles: What's the Deal? Walk with me through the gritty world of financials, and you’ll see that ESENTIA’s latest figures are a mixed bag with a tantalizing upside. We're talking about adjusted EBITDA ticking up to a cool $86 million in the third quarter of '26, a 1.3% lift from last year. Not too shabby, eh? Especially when you're grappling...

Continue Reading

Top 5 Most Recently Viewed Articles

Al Bowman Named Office Executive for Georgia and Tennessee

Updated Category News Views 246

Michael Baker International Elevates Al Bowman Michael Baker International is pleased to announce the promotion of Al Bowman, P.E., S.E., to the position of Office Executive for operations in Georgia and Tennessee. This change reflects the company's ongoing commitment to enhancing leadership and expertise within its ranks. Leadership Transition In his new role, Mr. Bowman...

Continue Reading
Top Stocks Captivating Investors: Palantir, Intel and More

Updated Category News Views 400

What’s Driving Investors’ Attention to Key Stocks? Major U.S. stock indices showed positive movement most recently. The Nasdaq rose slightly by 0.07%, reaching 20,041.26, while the S&P 500 saw a modest increase of 0.2% to close at 6,129.58. The Dow Jones Industrial Average also inched up, marking a 0.02% gain at 44,556.34. Palantir Technologies Inc. Shines Bright...

Continue Reading
Silver Tiger Secures C$40 Million for El Tigre Project Advances

Updated Category News Views 161

Silver Tiger Closes Major Financing Deal Silver Tiger Metals Inc. (TSXV:SLVR) recently finalized a significant financing agreement valued at C$40,004,000. The company successfully concluded a bought deal offering, allowing them to sell a total of 54,800,000 common shares at a price of C$0.73 each. This funding is crucial for further exploration and development of their...

Continue Reading
Insider Buying Spree at Waste Management: A Positive Sign?

Updated Category News Views 116

Recent Insider Purchases in Waste Management In an intriguing recent development, a notable insider purchase by William Plummer, a board member at Waste Management (NYSE: WM), has drawn attention. This purchase involved 696 shares worth approximately $158,301, as per a filing with the SEC. The Impact of Insider Trading Insider trading can serve as a vital indicator of a...

Continue Reading
Sampo plc's Significant Share Buybacks Announced Today

Updated Category News Views 185

Sampo plc's Recent Share Buybacks Sampo plc has initiated compelling share buybacks that aim to bolster investor confidence. Through strategic buybacks, the company intends to return value to shareholders while demonstrating its robust financial position. Details of the Buybacks On a recent trading day, significant acquisitions of A shares were reported. These include a...

Continue Reading